
UK’s NICE Recommends Coverage for Hereditary Angioedema Drug Takhzyro
According to a story from Angioedema News, the UK's National Institute for Health and Clinical Excellence (NICE) has officially recommended the drug lanadelumab (marketed as Takhzyro) for coverage under the…